ニュースGotham Group. partnered with Mercachem on Jul 9th '19.Gotham Therapeutics, a biotechnology company developing a novel drug class targeting RNA-modifying proteins, and Mercachem, the leading European contract research organization, today announced the generation of a high-quality compound library tailor-made for accelerated hit generation and hit-to-lead expansion against large parts of the epitranscriptomic target space.
